Princeton junior, 20, missing for FIVE DAYS

[erwinlatour914]

LONDON, Nov 19 (Reuters) – Britain’s Brexit minister David Frost said on Friday that significant gaps remained with the European Union across most issues relating to the Northern Irish protocol and that if no solution could be found, then Article 16 would be used.

“If no such solution can be found, we remain prepared to use the safeguard provisions under Article 16, which are a legitimate recourse under the Protocol in order for the government to meet its responsibilities to the people of Northern Ireland,” he said.

LONDON, Dec 17 (Reuters) – British negotiators are still trying to bridge gaps in trade talks with the European Union but ending a transition period without such an agreement remains the most likely outcome, Prime Minister Boris Johnson’s spokesman said again on Thursday.

At its annual general meeting in Mumbai, the Board of Control for Cricket in India (BCCI) also approved a women’s Indian Premier League, which is likely to begin in March next year, after the men’s event proved a massive hit.

For them, new treatments are still needed as they fight to stay alive long enough for the next scientific advance.
But most of us will emerge from our encounters with breast cancer scarred, sometimes emotionally traumatised and exhausted — but alive.

United Arab Emirates hosted this year’s Asia Cup which was shifted out of Sri Lanka because of political unrest in the island nation. (Reporting by Amlan Chakraborty in New Delhi; editing by Peter Rutherford and Christian Radnedge)

School officials say she ‘has not been in touch with her family or friends in several days,’ and sent out a ‘Tiger Alert’ to the school community at around 9.20pm Monday night reporting her missing, the reports.

Ewunetie is originally from northeast Ohio, and had received a full scholarship to the prestigious university in 2020, covering her tuition and fees, room and board, books and supplies, and travel expenses for four years.

Other types of breast cancer are seeing similar advances with the introduction of immunotherapy drugs and advances in genetic testing of tumours, which can help doctors identify women who don’t need chemotherapy at all and spare them its gruelling side-effects.

It was a shock — although like most women, one I had half expected every time I had a mammogram — and I was frightened.
But one of the things you don’t realise about breast cancer, until you are diagnosed with it, is the range of treatment for different tumours and how there are an ever-increasing number of options.

After a course of radiotherapy I was prescribed letrozole, is there science on the sat which my oncologist explained was now regarded as the more effective alternative to tamoxifen, the drug which had been the standard hormone therapy.

I’d been paranoid about such a diagnosis for a while because my mother had been treated for the disease twice, once in her early 50s and then again in her 60s, and Schweden so I had the nagging feeling that I was waiting my turn.

Fear does strange things to your brain. While an oncology professor tried to explain that it was a fast-growing, aggressive cancer and that I would need chemotherapy, surgery, radiotherapy — the whole shebang — I kept saying that I really shouldn’t be there, that my family history really wasn’t that bad.

The day I discovered that the scans to check whether the cancer had spread to other parts of my body were clear was one of the happiest of my life. Only at that point, two weeks after my initial diagnosis, did I feel able to tell my children I had cancer.

In 2015, the Royal Marsden, in West London, was running a five-year clinical trial for a new drug called pertuzumab — also known by its brand name Perjeta — which was already having almost miraculous results on my form of breast cancer in the U.S.

We aren’t there yet, but according to Cancer Research UK, ten-year breast cancer survival rates in the UK have nearly doubled since the 1970s, from four in ten women surviving their disease beyond ten years to around eight in ten now.

Given alongside chemo and surgery, anti-HER2 drugs mean that women like me, who once had a woeful prognosis, now have an 88 per cent chance of living for at least six years — and a growing chance of being cured entirely.

I was a single mother with a 13-year-old daughter.
I will never forget the first few weeks which followed; waking up drenched in sweat, adrenalin charging through my veins; the almost primeval fear that my life was about to end.

I will need to take it for many years — five, seven, ten, it isn’t clear — but as someone who happily took the contraceptive pill for a great many years, that kind of long-term medication has never bothered me.

I’d had what scientists call a ‘pathological complete response’. It felt like a miracle. We must never forget the estimated 35,000 women living with metastatic breast cancer, or the 32 women who die prematurely every day.

[Author]

Posts